Evidence map›Paper›PMID 39597734›Full record

ArticleMicroorganisms2024

Development of a Real-Time PCR Assay for the Detection of

Alexandr Shevtsov, Ayan Dauletov, Uinkul Izbanova, Alma Kairzhanova, Nailya Tursunbay, Vladimir Kiyan, Gilles Vergnaud

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexandr ShevtsovNational Center for Biotechnology, Astana 010000, Kazakhstan.ORCID 0000-0002-0307-1053
Ayan DauletovNational Center for Biotechnology, Astana 010000, Kazakhstan.
Uinkul IzbanovaAikimbayev's National Scientific Center for Especially Dangerous Infections, Almaty 050000, Kazakhstan.
Alma KairzhanovaNational Center for Biotechnology, Astana 010000, Kazakhstan.
Nailya TursunbayNational Center for Biotechnology, Astana 010000, Kazakhstan.
Vladimir KiyanNational Center for Biotechnology, Astana 010000, Kazakhstan.ORCID 0000-0001-9787-9151
Gilles VergnaudInstitute for Integrative Biology of the Cell (I2BC), Centre National de la Recherche Scientifique (CNRS), Commissariat à l'Énergie Atomique (CEA), Université Paris-Saclay, 91198 Gif-sur-Yvette, France.ORCID 0000-0003-0913-194X

Funding

Ministry of Science and High Education of the Republic of Kazakhstan AP14869313 "Study of geographic distribution and genetic diversity of Francisella tularensis subsp mediasiatica strains circulating in Kazakhstan".
6 · The paper itself

Abstract

Tularemia is an acute infectious disease classified as a natural focal infection, requiring continuous monitoring of both human and animal morbidity, as well as tracking of pathogen circulation in natural reservoirs and vectors. These efforts are essential for a comprehensive prevention and containment strategy. The causative agent,

Indexed as

Francisella spp.Francisella tularensis subsp. mediasiaticaISFtu1ISFtu2real-time PCR

Identifiers

PMID39597734
PMCPMC11596666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.